Status:
COMPLETED
Impact of SpHb Monitoring on Transfusion
Lead Sponsor:
Cairo University
Collaborating Sponsors:
Masimo Corporation
Conditions:
Anemia
Eligibility:
All Genders
15-60 years
Phase:
NA
Brief Summary
Continuous and noninvasive hemoglobin (SpHb) monitoring provides clinicians with real-time trending of changes or lack of changes in hemoglobin, which has the potential to alter red blood cell (RBC) t...
Detailed Description
Eligible patients scheduled for neurosurgeries were enrolled into either a standard care group (Control Group) or an intervention group (SpHb Group). The Control Group received typical anesthesia care...
Eligibility Criteria
Inclusion
- ASA 1,2 patients from 15 to 60 years old scheduled for neurosurgical procedure
Exclusion
- Exclusion criteria included significant liver or renal disease, coagulopathy, pregnancy, anemia, and patients scheduled for procedures with excepted low blood loss.
Key Trial Info
Start Date :
February 1 2012
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
December 1 2012
Estimated Enrollment :
106 Patients enrolled
Trial Details
Trial ID
NCT01906515
Start Date
February 1 2012
End Date
December 1 2012
Last Update
February 27 2014
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.